{"id":18458,"date":"2025-08-08T12:22:17","date_gmt":"2025-08-08T10:22:17","guid":{"rendered":"https:\/\/www.clarkemodet.com\/?p=18458"},"modified":"2025-09-16T14:47:43","modified_gmt":"2025-09-16T12:47:43","slug":"mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies","status":"publish","type":"post","link":"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/","title":{"rendered":"Mexico Recognizes ANVISA as the Reference Regulatory Authority for Medical Devices, Opening Opportunities for Brazilian Companies"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">In July 2025, Mexico\u2019s Federal Commission for the Protection against Sanitary Risks (COFEPRIS) published new guidelines establishing an&nbsp;<strong>abbreviated regulatory pathway<\/strong>&nbsp;for the registration of medicines and medical devices. One of the most significant developments is the&nbsp;<strong>recognition of Brazil\u2019s National Health Surveillance Agency (ANVISA)<\/strong>&nbsp;as a&nbsp;<strong>National Regulatory Authorities of Regional Reference (RNAr)<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This means that&nbsp;<strong>marketing authorizations and inspections conducted by ANVISA may now be accepted in Mexico<\/strong>, provided they meet the technical criteria set by COFEPRIS.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This recognition should not be seen merely as a diplomatic gesture. It reflects a technical endorsement of ANVISA\u2019s regulatory processes, particularly its ability to ensure the&nbsp;<strong>safety, efficacy, and quality<\/strong>&nbsp;of health products.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>The Concept of Reliance<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The World Health Organization defines&nbsp;<em>reliance<\/em>&nbsp;as the process by which a regulatory authority uses the assessments performed by another trusted authority as part of its own decision-making. Even when applying this model, the local authority retains full responsibility for the final decision.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Mutual trust requires reciprocal confidence, but also clear criteria, transparency, and accountability. When implemented properly, it can reduce duplication of effort and accelerate access to health technologies, facilitating the entry of Brazilian products into the Mexican market in a more agile and efficient manner.<\/p>\n\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\"><strong>Reliance, Recognition, and Work-Sharing<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">These three regulatory approaches are often confused but have distinct meanings:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Reliance<\/strong>: partial or full use of another authority\u2019s assessments, with the final decision remaining local<\/li>\n\n\n\n<li><strong>Recognition<\/strong>: full acceptance of another authority\u2019s decision, with no further evaluation<\/li>\n\n\n\n<li><strong>Work-sharing<\/strong>: simultaneous collaboration between authorities on joint assessments<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Understanding these distinctions is essential to accurately interpret the scope of COFEPRIS\u2019s new guidelines.<\/p>\n\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\"><strong>What COFEPRIS Has Established<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The guidelines, published in Mexico\u2019s Official Gazette, allow the country to recognize the requirements, testing, and evaluation procedures of authorities such as the&nbsp;<strong>FDA (USA), EMA (EU), Swissmedic (Switzerland), Health Canada, TGA (Australia)<\/strong>, and now&nbsp;<strong>ANVISA (Brazil)<\/strong>&nbsp;as equivalent.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This enables Brazilian companies with ANVISA-approved registrations to use those approvals as the basis for seeking registration in Mexico via the&nbsp;<strong>abbreviated pathway<\/strong>. The same applies to inspections conducted by ANVISA at medical device manufacturing sites.<\/p>\n\n\n\n<p class=\"has-medium-font-size wp-block-paragraph\"><strong>Opportunities for Industry<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This decision offers a significant competitive advantage for Brazilian companies by reducing the time and costs associated with entering the Mexican market. With COFEPRIS&#8217; recognition of ANVISA&#8217;s evaluations, Brazilian companies can take advantage of prior product approvals, facilitating their registration in Mexico through an abbreviated regulatory pathway.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">If applied rigorously, reliance can benefit the public by facilitating&nbsp;<strong>faster access to safe and effective health technologies<\/strong>. However, this benefit depends on maintaining high standards of quality and regulatory oversight.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">COFEPRIS\u2019s recognition of ANVISA marks a significant step toward&nbsp;<strong>regulatory convergence in Latin America<\/strong>. It presents a concrete opportunity for industry, a test of maturity for regulatory systems, and a validation of Brazil\u2019s regulatory model\u2014provided that Brazil continues to invest in&nbsp;<strong>quality, transparency, and international cooperation<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">If your company operates in the medical device sector and is considering expansion into the Mexican market, now is the time to&nbsp;<strong>review your regulatory strategy<\/strong>&nbsp;and assess how the abbreviated pathway can be applied&nbsp;<strong>safely and effectively<\/strong>&nbsp;to your business.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">COFEPRIS&#8217; recognition of ANVISA marks an important step towards regulatory convergence in Latin America. For Brazilian companies, this not only represents an opportunity to access the Mexican market more quickly, but also a validation of Brazil&#8217;s regulatory model in the international context. Brazilian companies should take advantage of this opportunity to review their regulatory strategies and assess how this simplified process can accelerate their entry into Mexico, reducing time and costs in the registration process.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In July 2025, Mexico\u2019s Federal Commission for the Protection against Sanitary Risks (COFEPRIS) published new guidelines establishing an&nbsp;abbreviated regulatory pathway&nbsp;for the registration of medicines and medical devices. One of the most significant developments is the&nbsp;recognition of Brazil\u2019s National Health Surveillance Agency (ANVISA)&nbsp;as a&nbsp;National Regulatory Authorities of Regional Reference (RNAr) This means that&nbsp;marketing authorizations and inspections [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":18277,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[79],"tags":[],"country":[30,4],"industry":[100],"class_list":["post-18458","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-legislative-news","country-br","country-mx","industry-medical-technology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Mexico Recognizes ANVISA as the Reference Regulatory Authority for Medical Devices, Opening Opportunities for Brazilian Companies - ClarkeModet<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mexico Recognizes ANVISA as the Reference Regulatory Authority for Medical Devices, Opening Opportunities for Brazilian Companies\" \/>\n<meta property=\"og:description\" content=\"In July 2025, Mexico\u2019s Federal Commission for the Protection against Sanitary Risks (COFEPRIS) published new guidelines establishing an&nbsp;abbreviated regulatory pathway&nbsp;for the registration of medicines and medical devices. One of the most significant developments is the&nbsp;recognition of Brazil\u2019s National Health Surveillance Agency (ANVISA)&nbsp;as a&nbsp;National Regulatory Authorities of Regional Reference (RNAr) This means that&nbsp;marketing authorizations and inspections [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/\" \/>\n<meta property=\"og:site_name\" content=\"ClarkeModet\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-08T10:22:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-16T12:47:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/oldweb2025.clarkemodet.com\/wp-content\/uploads\/2025\/08\/cofepris_anvisa_social.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Violeta Jim\u00e9nez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Mexico Recognizes ANVISA as the Reference Regulatory Authority for Medical Devices, Opening Opportunities for Brazilian Companies\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/oldweb2025.clarkemodet.com\/wp-content\/uploads\/2025\/08\/cofepris_anvisa_social.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@clarkemodet\" \/>\n<meta name=\"twitter:site\" content=\"@clarkemodet\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Violeta Jim\u00e9nez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/\"},\"author\":{\"name\":\"Violeta Jim\u00e9nez\",\"@id\":\"https:\/\/oldweb2025.clarkemodet.com\/#\/schema\/person\/a0b997c100260c6c2ded81367bf0ff76\"},\"headline\":\"Mexico Recognizes ANVISA as the Reference Regulatory Authority for Medical Devices, Opening Opportunities for Brazilian Companies\",\"datePublished\":\"2025-08-08T10:22:17+00:00\",\"dateModified\":\"2025-09-16T12:47:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/\"},\"wordCount\":634,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/oldweb2025.clarkemodet.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/oldweb2025.clarkemodet.com\/wp-content\/uploads\/2025\/08\/cofepris_anvisa_destacada.jpg\",\"articleSection\":[\"Legislative news\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/\",\"url\":\"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/\",\"name\":\"Mexico Recognizes ANVISA as the Reference Regulatory Authority for Medical Devices, Opening Opportunities for Brazilian Companies - ClarkeModet\",\"isPartOf\":{\"@id\":\"https:\/\/oldweb2025.clarkemodet.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/oldweb2025.clarkemodet.com\/wp-content\/uploads\/2025\/08\/cofepris_anvisa_destacada.jpg\",\"datePublished\":\"2025-08-08T10:22:17+00:00\",\"dateModified\":\"2025-09-16T12:47:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/#primaryimage\",\"url\":\"https:\/\/oldweb2025.clarkemodet.com\/wp-content\/uploads\/2025\/08\/cofepris_anvisa_destacada.jpg\",\"contentUrl\":\"https:\/\/oldweb2025.clarkemodet.com\/wp-content\/uploads\/2025\/08\/cofepris_anvisa_destacada.jpg\",\"width\":1280,\"height\":960},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/oldweb2025.clarkemodet.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mexico Recognizes ANVISA as the Reference Regulatory Authority for Medical Devices, Opening Opportunities for Brazilian Companies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/oldweb2025.clarkemodet.com\/#website\",\"url\":\"https:\/\/oldweb2025.clarkemodet.com\/\",\"name\":\"ClarkeModet\",\"description\":\"Somos el mayor grupo especializado en la protecci\u00f3n de tu Propiedad Industrial e Intelectual en pa\u00edses de habla hispana y portuguesa.\",\"publisher\":{\"@id\":\"https:\/\/oldweb2025.clarkemodet.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/oldweb2025.clarkemodet.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/oldweb2025.clarkemodet.com\/#organization\",\"name\":\"ClarkeModet\",\"url\":\"https:\/\/oldweb2025.clarkemodet.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/oldweb2025.clarkemodet.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/oldweb2025.clarkemodet.com\/wp-content\/uploads\/2023\/03\/AF_CLARKEMODET_VP_POS_RGB.png\",\"contentUrl\":\"https:\/\/oldweb2025.clarkemodet.com\/wp-content\/uploads\/2023\/03\/AF_CLARKEMODET_VP_POS_RGB.png\",\"width\":1431,\"height\":812,\"caption\":\"ClarkeModet\"},\"image\":{\"@id\":\"https:\/\/oldweb2025.clarkemodet.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/clarkemodet\",\"https:\/\/www.linkedin.com\/company\/clarkemodet\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/oldweb2025.clarkemodet.com\/#\/schema\/person\/a0b997c100260c6c2ded81367bf0ff76\",\"name\":\"Violeta Jim\u00e9nez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/oldweb2025.clarkemodet.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/53acb3c168d98de48c16699404aa91b4ff6c6938a0a8b80a6e35ada20c908c82?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/53acb3c168d98de48c16699404aa91b4ff6c6938a0a8b80a6e35ada20c908c82?s=96&d=mm&r=g\",\"caption\":\"Violeta Jim\u00e9nez\"},\"url\":\"https:\/\/oldweb2025.clarkemodet.com\/en\/author\/vjimenezb\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mexico Recognizes ANVISA as the Reference Regulatory Authority for Medical Devices, Opening Opportunities for Brazilian Companies - ClarkeModet","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Mexico Recognizes ANVISA as the Reference Regulatory Authority for Medical Devices, Opening Opportunities for Brazilian Companies","og_description":"In July 2025, Mexico\u2019s Federal Commission for the Protection against Sanitary Risks (COFEPRIS) published new guidelines establishing an&nbsp;abbreviated regulatory pathway&nbsp;for the registration of medicines and medical devices. One of the most significant developments is the&nbsp;recognition of Brazil\u2019s National Health Surveillance Agency (ANVISA)&nbsp;as a&nbsp;National Regulatory Authorities of Regional Reference (RNAr) This means that&nbsp;marketing authorizations and inspections [&hellip;]","og_url":"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/","og_site_name":"ClarkeModet","article_published_time":"2025-08-08T10:22:17+00:00","article_modified_time":"2025-09-16T12:47:43+00:00","og_image":[{"width":900,"height":600,"url":"https:\/\/oldweb2025.clarkemodet.com\/wp-content\/uploads\/2025\/08\/cofepris_anvisa_social.jpg","type":"image\/jpeg"}],"author":"Violeta Jim\u00e9nez","twitter_card":"summary_large_image","twitter_title":"Mexico Recognizes ANVISA as the Reference Regulatory Authority for Medical Devices, Opening Opportunities for Brazilian Companies","twitter_image":"https:\/\/oldweb2025.clarkemodet.com\/wp-content\/uploads\/2025\/08\/cofepris_anvisa_social.jpg","twitter_creator":"@clarkemodet","twitter_site":"@clarkemodet","twitter_misc":{"Written by":"Violeta Jim\u00e9nez","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/#article","isPartOf":{"@id":"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/"},"author":{"name":"Violeta Jim\u00e9nez","@id":"https:\/\/oldweb2025.clarkemodet.com\/#\/schema\/person\/a0b997c100260c6c2ded81367bf0ff76"},"headline":"Mexico Recognizes ANVISA as the Reference Regulatory Authority for Medical Devices, Opening Opportunities for Brazilian Companies","datePublished":"2025-08-08T10:22:17+00:00","dateModified":"2025-09-16T12:47:43+00:00","mainEntityOfPage":{"@id":"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/"},"wordCount":634,"commentCount":0,"publisher":{"@id":"https:\/\/oldweb2025.clarkemodet.com\/#organization"},"image":{"@id":"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/#primaryimage"},"thumbnailUrl":"https:\/\/oldweb2025.clarkemodet.com\/wp-content\/uploads\/2025\/08\/cofepris_anvisa_destacada.jpg","articleSection":["Legislative news"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/","url":"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/","name":"Mexico Recognizes ANVISA as the Reference Regulatory Authority for Medical Devices, Opening Opportunities for Brazilian Companies - ClarkeModet","isPartOf":{"@id":"https:\/\/oldweb2025.clarkemodet.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/#primaryimage"},"image":{"@id":"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/#primaryimage"},"thumbnailUrl":"https:\/\/oldweb2025.clarkemodet.com\/wp-content\/uploads\/2025\/08\/cofepris_anvisa_destacada.jpg","datePublished":"2025-08-08T10:22:17+00:00","dateModified":"2025-09-16T12:47:43+00:00","breadcrumb":{"@id":"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/#primaryimage","url":"https:\/\/oldweb2025.clarkemodet.com\/wp-content\/uploads\/2025\/08\/cofepris_anvisa_destacada.jpg","contentUrl":"https:\/\/oldweb2025.clarkemodet.com\/wp-content\/uploads\/2025\/08\/cofepris_anvisa_destacada.jpg","width":1280,"height":960},{"@type":"BreadcrumbList","@id":"https:\/\/oldweb2025.clarkemodet.com\/en\/legislative-news\/mexico-recognizes-anvisa-as-the-reference-regulatory-authority-for-medical-devices-opening-opportunities-for-brazilian-companies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/oldweb2025.clarkemodet.com\/en\/"},{"@type":"ListItem","position":2,"name":"Mexico Recognizes ANVISA as the Reference Regulatory Authority for Medical Devices, Opening Opportunities for Brazilian Companies"}]},{"@type":"WebSite","@id":"https:\/\/oldweb2025.clarkemodet.com\/#website","url":"https:\/\/oldweb2025.clarkemodet.com\/","name":"ClarkeModet","description":"Somos el mayor grupo especializado en la protecci\u00f3n de tu Propiedad Industrial e Intelectual en pa\u00edses de habla hispana y portuguesa.","publisher":{"@id":"https:\/\/oldweb2025.clarkemodet.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/oldweb2025.clarkemodet.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/oldweb2025.clarkemodet.com\/#organization","name":"ClarkeModet","url":"https:\/\/oldweb2025.clarkemodet.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/oldweb2025.clarkemodet.com\/#\/schema\/logo\/image\/","url":"https:\/\/oldweb2025.clarkemodet.com\/wp-content\/uploads\/2023\/03\/AF_CLARKEMODET_VP_POS_RGB.png","contentUrl":"https:\/\/oldweb2025.clarkemodet.com\/wp-content\/uploads\/2023\/03\/AF_CLARKEMODET_VP_POS_RGB.png","width":1431,"height":812,"caption":"ClarkeModet"},"image":{"@id":"https:\/\/oldweb2025.clarkemodet.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/clarkemodet","https:\/\/www.linkedin.com\/company\/clarkemodet\/"]},{"@type":"Person","@id":"https:\/\/oldweb2025.clarkemodet.com\/#\/schema\/person\/a0b997c100260c6c2ded81367bf0ff76","name":"Violeta Jim\u00e9nez","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/oldweb2025.clarkemodet.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/53acb3c168d98de48c16699404aa91b4ff6c6938a0a8b80a6e35ada20c908c82?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/53acb3c168d98de48c16699404aa91b4ff6c6938a0a8b80a6e35ada20c908c82?s=96&d=mm&r=g","caption":"Violeta Jim\u00e9nez"},"url":"https:\/\/oldweb2025.clarkemodet.com\/en\/author\/vjimenezb\/"}]}},"_links":{"self":[{"href":"https:\/\/oldweb2025.clarkemodet.com\/en\/wp-json\/wp\/v2\/posts\/18458","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oldweb2025.clarkemodet.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/oldweb2025.clarkemodet.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/oldweb2025.clarkemodet.com\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/oldweb2025.clarkemodet.com\/en\/wp-json\/wp\/v2\/comments?post=18458"}],"version-history":[{"count":2,"href":"https:\/\/oldweb2025.clarkemodet.com\/en\/wp-json\/wp\/v2\/posts\/18458\/revisions"}],"predecessor-version":[{"id":18460,"href":"https:\/\/oldweb2025.clarkemodet.com\/en\/wp-json\/wp\/v2\/posts\/18458\/revisions\/18460"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/oldweb2025.clarkemodet.com\/en\/wp-json\/wp\/v2\/media\/18277"}],"wp:attachment":[{"href":"https:\/\/oldweb2025.clarkemodet.com\/en\/wp-json\/wp\/v2\/media?parent=18458"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/oldweb2025.clarkemodet.com\/en\/wp-json\/wp\/v2\/categories?post=18458"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/oldweb2025.clarkemodet.com\/en\/wp-json\/wp\/v2\/tags?post=18458"},{"taxonomy":"country","embeddable":true,"href":"https:\/\/oldweb2025.clarkemodet.com\/en\/wp-json\/wp\/v2\/country?post=18458"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/oldweb2025.clarkemodet.com\/en\/wp-json\/wp\/v2\/industry?post=18458"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}